METROPOLITAN LIFE INSURANCE CO/NY - NURIX THERAPEUTICS INC ownership

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 127 filers reported holding NURIX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of NURIX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,246
-21.3%
2,7030.0%0.00%0.0%
Q2 2023$27,003
-9.0%
2,7030.0%0.00%0.0%
Q4 2022$29,679
-15.7%
2,7030.0%0.00%
-50.0%
Q3 2022$35,220
+2.8%
2,7030.0%0.00%0.0%
Q2 2022$34,247
+14.9%
2,703
+27.0%
0.00%
+100.0%
Q1 2022$29,813
-88.6%
2,128
-76.4%
0.00%
-75.0%
Q4 2021$261,100
-3.4%
9,0190.0%0.00%0.0%
Q3 2021$270,209
+25.0%
9,019
+29.8%
0.00%
+33.3%
Q1 2021$216,107
+88.2%
6,951
+99.0%
0.00%
+50.0%
Q4 2020$114,850
-5.8%
3,4930.0%0.00%0.0%
Q3 2020$121,9413,4930.00%
Other shareholders
NURIX THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 15,823$163,2930.00%
View complete list of NURIX THERAPEUTICS INC shareholders